Your Best Stock

Abbott Laboratories ABT

$101.69
−$1.80 (-1.74%)
Market open · Sep 24, 2:00 pm ET
After hours $103.49 0.00%
Open$103.77
Prev close$103.49
Day range$101.55 – $104.22
Volume2.19M
Market cap$175.96B
P/E (TTM)32.9
Dividend yield2.40%

Earnings

Average move on report day±4.8%last 16 reports
Closed higher7 of 1644% of the time
Best reaction+10.7%
Worst reaction-10.0%

Stock move on the day after each report

+3.7%2023/Q3-2.8%2023/Q4-3.0%2024/Q1-4.4%2024/Q2+1.5%2024/Q3+0.8%2024/Q4+2.8%2025/Q1-8.5%2025/Q2-2.4%2025/Q3-10.0%2025/Q4-6.0%2026/Q1+10.7%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q216 Jul 2026Pre Market±4.1%+10.71%Bigger than priced
2026/Q116 Apr 2026Pre Market±4.7%-6.00%Bigger than priced
2025/Q422 Jan 2026Pre Market±4.1%-10.04%Bigger than priced
2025/Q315 Oct 2025Pre Market±4.7%-2.43%Within range
2025/Q217 Jul 2025Pre Market±4.7%-8.52%Bigger than priced
2025/Q116 Apr 2025Pre Market±4.8%+2.76%Within range
2024/Q422 Jan 2025Pre Market±4.0%+0.85%Within range
2024/Q316 Oct 2024Pre Market±4.3%+1.53%Within range
2024/Q218 Jul 2024Pre Market±4.7%-4.40%Within range
2024/Q117 Apr 2024Pre Market±4.6%-3.03%Within range
2023/Q424 Jan 2024Pre Market±3.7%-2.83%Within range
2023/Q318 Oct 2023Pre Market±4.1%+3.71%Within range
2023/Q220 Jul 2023Pre Market±4.1%+4.24%Bigger than priced
2023/Q119 Apr 2023Pre Market±3.3%+7.82%Bigger than priced
2022/Q425 Jan 2023Pre Market±4.0%-1.36%Within range
2022/Q319 Oct 2022Pre Market±3.8%-6.54%Bigger than priced

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Medical devices$5.85B 46.5%
  • Diagnostic Products$3.09B 24.6%
  • Nutritional Products$2.14B 17.0%
  • Established Pharmaceutical Products$1.50B 11.9%
  • Other$5.00M 0.0%

Latest reported quarter: Q2, ended Jun 2026

Revenue$12.59B+13.0% YoY
Operating profit$1.69B-17.5% YoY
Net profit$928.00M-47.8% YoY
Diluted EPS$0.53-47.5% YoY
Free cash flow$1.99B+28.9% YoY
Operating cash flow$2.49B

Revenue, last 8 quarters

$10.6BSep '24$11.0BDec '24$10.4BMar '25$11.1BJun '25$11.4BSep '25$11.5BDec '25$11.2BMar '26$12.6BJun '26

Net profit, last 8 quarters

$1.6BSep '24$9.2BDec '24$1.3BMar '25$1.8BJun '25$1.6BSep '25$1.8BDec '25$1.1BMar '26$928.0MJun '26

Profitability & balance sheet

Gross margin56.6%
Operating margin15.8%
Net margin11.6%
Return on equity10.7%
Return on assets5.6%
Return on invested capital7.8%
Current ratio1.38
Liabilities / assets52.6%
Cash & investments$5.60B
Total debt$32.61B
Net cash (debt)-$27.01B
Free cash flow / sales16.8%
Scroll to Top